Perrigo

perrigo

Perrigo Reports Record First Quarter Revenue, Earnings

The Allegan-based generic drug and health products manufacturer Perrigo Co. (Nasdaq: PRGO) Wednesday reported net income of $106 million or $1.12 a share in the first fiscal quarter ended Sept. 29, up from $70.5 or 75 cents a share in the same quarter a year earlier.

WWJ Newsradio 950–11/07/2012

perrigo

Perrigo: FDA Tentative Approval For OTC Omeprazole-Sodium Bicarbonate

ALLEGAN — Allegan-based Perrigo Co. (Nasdaq: PRGO) today announced that it has received tentative approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application to market over-the-counter omeprazole and sodium bicarbonate capsules 20mg/1100mg, […]

WWJ Newsradio 950–10/16/2012

perrigo

Perrigo Receives FDA Approval To Market Mini Nicotine Lozenges

The Perrigo Co. announced that it has received approval from the United States Food and Drug Administration for its Abbreviated New Drug Applications to market over-the-counter nicotine polacrilex mini lozenge USP, 2 mg (mint flavor) and 4 mg (mint flavor).

WWJ Newsradio 950–10/10/2012

Event Notices From October 8

The latest event and meeting notices from Michigan’s technology-focused companies, institutions and groups

WWJ Newsradio 950–10/09/2012

perrigo

Perrigo To Acquire Sergeant’s Pet Care Products For $285 Million

Perrigo Co. announced that it has signed a definitive agreement to acquire substantially all of the assets of Sergeant’s Pet Care Products Inc., a privately held, Omaha, Neb.-based manufacturer of over-the-counter companion animal health care products, for approximately $285 million in cash.

WWJ Newsradio 950–09/13/2012

perrigo

Perrigo and Tris Pharma Launch Store Brand Version of Delsym

Allegan-based Perrigo Co. and Tris Pharma Inc. announced the commercial launch of a major new store brand product. The new product is equivalent to Delsym extended-release oral liquid suspension containing dextromethorphan polistirex and will be marketed under major U.S. retailer and wholesalers’ store brands or own label brands.

WWJ Newsradio 950–08/27/2012

perrigo

Perrigo Launches Morphine After FDA Approval

The Allegan-based health and beauty products manufacturer Perrigo Co. (Nasdaq: PRGO) said Wednesday it has received final approval from the United States Food and Drug Administration for its abbreviated new drug application for morphine sulfate 100ml/5 percent oral solution.

WWJ Newsradio 950–08/08/2012

perrigo

Perrigo Announces Settlement of Clobetasol Propionate E-Foam 0.05% Patent Litigation

Perrigo Co. announced that it has agreed to settle its Hatch-Waxman litigation relating to Clobetasol propionate emulsion foam, 0.05% brought by Stiefel Research Australia Pty. Ltd., a GSK company.

WWJ Newsradio 950–06/11/2012

perrigo

Perrigo Announces FDA Approval Of Generic Delsym

Perrigo Co. (Nasdaq: PRGO) announced that the United States Food and Drug Administration has granted final approval to Tris Pharma for its abbreviated new drug application for Dextromethorphan Polistirex Extended-Release Oral Suspension, the store brand equivalent to Reckitt Benckiser’s Delsym suspension.

WWJ Newsradio 950–05/31/2012

perrigo

Perrigo Receives FDA Approval for Butoconazole Nitrate 2 Percent Vaginal Cream

Perrigo Co. announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for butoconazole nitrate 2% vaginal cream, the generic equivalent of Gynazole·1.

WWJ Newsradio 950–05/23/2012

more

previous

Follow

Get every new post delivered to your Inbox.

Join 2,065 other followers